Literature DB >> 36043974

Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice.

Giorgio Ciprandi1, Maria Angela Tosca2, Irene Schiavetti3, Roberta Olcese4, Michele Miraglia Del Giudice5.   

Abstract

Background Reversible bronchial obstruction characterizes asthma. Spirometry is the gold standard to assess airflow, and FEV1 is the most reliable parameter in this regard. However, many children with asthma have FEV1 within the normal range despite uncontrolled asthma and worsening. Therefore, FEF25-75 has been proposed as a valuable marker of early airflow impairment. This study aimed at investigating FEF25-75 in a cohort of children with newly diagnosed asthma. Methods 381 children (122 females, mean age 11.6 years) were consecutively visited and had a new asthma diagnosis. In addition, Spirometry, type-2 phenotyping, asthma control assessment, and ACT were performed. Results 72 (18.9%) asthmatic children had impaired FEF25-75, such as <65% of predicted. Low FEF25-75 was associated with lower FVC and FEV1/FVC values (OR 1.11 and 1.32, respectively). Children with normal FEV1 but impaired FEF25-75 had more frequently uncontrolled asthma (15.8% vs. 32.4%) than children with both parameters within the normal range. Conclusions FEF25-75 deserves adequate and careful consideration in children with asthma, and the presence of impaired FEF25-75 values suggests a more compelling approach.

Entities:  

Mesh:

Year:  2022        PMID: 36043974      PMCID: PMC9534232          DOI: 10.23750/abm.v93i4.12550

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  25 in total

1.  Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.

Authors:  G Ciprandi; M Capasso; S Leonardi; E Lionetti; M La Rosa; C Salpietro; M Miraglia Del Giudice; I Cirillo; M Tosca; G L Marseglia
Journal:  J Biol Regul Homeost Agents       Date:  2012 Jan-Mar       Impact factor: 1.711

2.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

3.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

4.  The real-world "ControL'Asma" study: a nationwide taskforce on asthma control in children and adolescents.

Authors:  Maria Angela Tosca; Gian Luigi Marseglia; Giorgio Ciprandi
Journal:  Allergol Immunopathol (Madr)       Date:  2021-01-02       Impact factor: 1.667

5.  The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting.

Authors:  Giorgio Ciprandi; Ignazio Cirillo
Journal:  Expert Rev Respir Med       Date:  2019-10-04       Impact factor: 3.772

6.  Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma.

Authors:  G Ciprandi; M A Tosca; I Cirillo; E Lionetti; S Leonardi; M Miraglia Del Giudice; M La Rosa; A Salpietro; M Capasso; G L Marseglia
Journal:  J Biol Regul Homeost Agents       Date:  2012 Jan-Mar       Impact factor: 1.711

7.  Development of the asthma control test: a survey for assessing asthma control.

Authors:  Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

8.  FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1.

Authors:  Rundong Qin; Jiaying An; Jiaxing Xie; Renbin Huang; Yanqing Xie; Li He; Hui Xv; Geng Qian; Jing Li
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-30

9.  Forced Expiratory Flow (FEF25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Authors:  Stanley J Szefler; Stanley Goldstein; Christian Vogelberg; George W Bensch; John Given; Branko Jugovic; Michael Engel; Petra M Moroni-Zentgraf; Ralf Sigmund; Eckard H Hamelmann
Journal:  Pulm Ther       Date:  2020-05-12

10.  FEF25-75% Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Do Sun Kwon; Yong Jun Choi; Tae Hee Kim; Min Kwang Byun; Jae Hwa Cho; Hyung Jung Kim; Hye Jung Park
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.